The 25,000 SF Leptospiria Vaccine Manufacturing facility provided a large shell area for production and was constructed with the constant need for clean room production areas. The construction included steel, precast, and structural slab structure, which resulted in eight to ten clean lab rooms that can be used for additional production processes. One of the biggest obstacles was the restricted site that had a very limited staging area.